1496PIntracranial activity of ensartinib in patients with anaplastic lymphoma kinase positive (ALK+) non-small cell lung cancer (NSCLC). (23rd October 2018) - Wakelee, H; Reckamp, K L; Leal, T A; Patel, S P; Blumenschein, G; Shum, E; Nieva, J; Oxnard, G; Sanborn, R E; Waqar, S; Zeman, K; Dukart, G; et al.